Ovid Therapeutics Inc. · NASDAQ:OVID

Takeda Pharmaceutical Company Limited reported a 12.30% stake in Ovid Therapeutics Inc. (Schedule 13G/A)

Event Dec 8, 2025 · Filed Dec 9, 2025

Takeda Pharmaceutical Company Limited reported a 12.30% stake in Ovid Therapeutics Inc., 8,781,996 shares, as a passive investor on Dec 8, 2025. Filed Dec 9, 2025 (Schedule 13G/A).

Stake
12.30%
Shares
8,781,996
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Takeda Pharmaceutical Company Limited12.30%8,781,996
Takeda Pharmaceutical U.S.A., Inc.9.80%7,000,000

Source

View original at SEC

Related